Elon Musk's brain-chip company Neuralink is set to implant its revolutionary Blindsight chip on its first human patient in 2025. The test chip, approved by the ...

Elon Musk’s brain chip company, Neuralink, is aiming to achieve a major medical milestone by the end of 2025 with the first human implantation of its artificial visual prosthesis, Blindsight. The ...

The Tesla CEO said that Neuralink, another one of his tech companies, planned on implanting its new brain chip, Blindsight, into a human patient for the first time in late 2025. Newsweek contacted ...

Neuralink received US FDA approval for the Blindsight chip in September 2024. It was designated as a 'breakthrough device'.

Neuralink’s Blindsight implant aims to restore vision for the blind using a brain-computer interface, with future potential ...

Elon Musk's Neuralink has been awarded breakthrough status from the FDA for an implantable chip – dubbed Blindsight – that promises to restore the sight of people with vision impairment.

Neuralink is now developing a brain chip that will help blind people see again. Musk recently announced that it is known as Blindsight and will be implanted into a human for the first time this year.

Elon Musks Neuralink is set to revolutionize vision restoration with its groundbreaking Blindsight technology, aimed at giving sight back to the blind. With human trials starting by 2025, this ...

Elon Musk's startup, Neuralink, plans to implant its artificial visual prosthesis, 'Blindsight', in a human for the first time by late 2025.

Neuralink seeks quadriplegic patients for its brain implant trial, enabling thought-controlled computer use and advancing ...

The experimental device, known as Blindsight, "will enable even those who have lost both eyes and their optic nerve to see," Musk said in a post on X. Neuralink did not immediately respond to a ...

The US Food and Drug Administration (FDA) has awarded a "Breakthrough Device" status to Neuralink’s experimental vision-restoring implant, Blindsight. This designation is intended to fast-track ...